Request a rep
Thank you for your interest in Remodulin
If you would like to speak with a United Therapeutics Representative, please fill out the form and click submit, and someone will contact you shortly.
*Required field.
If you would like to speak with a United Therapeutics Representative, please fill out the form and click submit, and someone will contact you shortly.
*Required field.
Important Safety Information
Warnings and Precautions
Adverse Reactions
Drug Interactions
Specific Populations
Indication
Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%).
In patients with PAH requiring transition from epoprostenol, Remodulin is indicated to diminish the rate of clinical deterioration. Consider the risks and benefits of each drug prior to transition.
REMISIhcpOct19
Please see accompanying Full Prescribing Information for Remodulin.
For additional information, visit www.remodulin.com or call Customer Service Line at 1-877-UNITHER (1-877-864-8437).
Important Safety Information
Warnings and Precautions
Adverse Reactions
Drug Interactions
Specific Populations
Indication
Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%).
In patients with PAH requiring transition from epoprostenol, Remodulin is indicated to diminish the rate of clinical deterioration. Consider the risks and benefits of each drug prior to transition.
REMISIhcpOct19
Please see accompanying Full Prescribing Information for Remodulin.
For additional information, visit www.remodulin.com or call Customer Service Line at 1-877-UNITHER (1-877-864-8437).
Click CONTINUE to proceed or CLOSE to return to Remodulinpro.com